Transgene SA (OTCPK:TRGNF)
$ 1.59 0 (0%) Market Cap: 95.63 Mil Enterprise Value: 79.82 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 38/100

Transgene SA Conference Call Transcript

May 05, 2023 / 02:00PM GMT
Release Date Price: $2.05
Operator

Hello, and welcome to the Transgene conference call. My name is Ben, and I will be the coordinator for today's call. Please note, this call is being recorded. (Operator Instructions) I will now hand you over to your host, Lucie Larguier, Head of Investor Relations, to begin today's conference. Thank you.

Lucie Larguier
Transgene SA - Director of Corporate Communications & IR

Thank you, and hello, everyone. So I have the pleasure today to introduce you to Dr. Alessandro Riva, who has just been appointed Chairman and CEO, Transgene, along with Hedi Ben Brahim, we will review today's news and answer your questions. Before I turn the call over to Alessandro Riva, I'd like to remind everyone that today's discussion contains forward-looking statements, which are subject to numerous risks and uncertainties. If you're listening to this webcast on the Internet, you will not be able to ask questions. If you wish to ask questions, please make sure that you join us via one of the conference call numbers that are available in today's press release. With this, I now turn

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot